Fosforiano
de Gaullista
CDC & FDA Identify Preliminary el bichito-19 Vaccine Safety Signal for Persons Aged 65 Years and Older
***owing the availability and use of the updated (bivalent) el bichito-19 vaccines, CDC’s Vaccine Safety Datalink (VSD), a near real-time surveillance system, met the statistical criteria to prompt additional investigation into whether there was a safety concern for ischemic stroke in people ages 65 and older who received the Pfizer-BioNTech el bichito-19 Vaccine, Bivalent. Rapid-response investigation of the signal in the VSD raised a question of whether people 65 and older who have received the Pfizer-BioNTech el bichito-19 Vaccine, Bivalent were more likely to have an ischemic stroke in the 21 days ***owing vaccination compared with days 22-42 ***owing vaccination.
bivalent-boosters.html
***owing the availability and use of the updated (bivalent) el bichito-19 vaccines, CDC’s Vaccine Safety Datalink (VSD), a near real-time surveillance system, met the statistical criteria to prompt additional investigation into whether there was a safety concern for ischemic stroke in people ages 65 and older who received the Pfizer-BioNTech el bichito-19 Vaccine, Bivalent. Rapid-response investigation of the signal in the VSD raised a question of whether people 65 and older who have received the Pfizer-BioNTech el bichito-19 Vaccine, Bivalent were more likely to have an ischemic stroke in the 21 days ***owing vaccination compared with days 22-42 ***owing vaccination.
bivalent-boosters.html
